Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Brock

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
The Lancet. Healthy Longevity|September 13, 2022
Discontinuation of diabetes medication in the 10 years before death in Denmark: a register-based studyVanja Kosjerina, Bendix Carstensen, Marit Eika Jørgensen, et al.
Molecular and Cellular Endocrinology|November 23, 2006
Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obeseKamille Smidt, Steen B Pedersen, Birgitte Brock, et al.
Frontiers in Pharmacology|December 6, 2016
Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis RatsBrian DellaValle, Gitte S Brix, Birgitte Brock, et al.
World Journal of Diabetes|February 22, 2019
Quantities of comorbidities affects physical, but not mental health related quality of life in type 1 diabetes with confirmed polyneuropathyAnne-Marie L Wegeberg, Theresa Meldgaard, Sofie Hyldahl, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysisMikkel Tøttrup, Tore Forsingdal Hardlei, Michael Bendtsen, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2015
Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumoniaKristina Öbrink-Hansen, Tore Forsingdal Hardlei, Birgitte Brock, et al.
Expert Opinion on Therapeutic Targets|July 14, 2011
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetesAnn Mosegaard Bak, Lærke Egefjord, Michael Gejl, et al.
Basic & Clinical Pharmacology & Toxicology|August 25, 2015
Detection of Patients at High Risk of Medication Errors: Development and Validation of an AlgorithmEva Aggerholm Saedder, Marianne Lisby, Lars Peter Nielsen, et al.
Basic & Clinical Pharmacology & Toxicology|February 24, 2021
Subcutaneous adipose tissue composition and function are unaffected by liraglutide-induced weight loss in adults with type 1 diabetesAnne-Marie Wegeberg, Theresa Meldgaard, Amanda Baek, et al.
Scientific Reports|July 13, 2023
Adynamic response to cold pain reflects dysautonomia in type 1 diabetes and polyneuropathyThomas Arendt Nielsen, Søren Lundbye-Christensen, Yoanna Krasimirova Dimitrova, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
The Lancet. Healthy Longevity|September 13, 2022
Discontinuation of diabetes medication in the 10 years before death in Denmark: a register-based studyVanja Kosjerina, Bendix Carstensen, Marit Eika Jørgensen, et al.
Molecular and Cellular Endocrinology|November 23, 2006
Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obeseKamille Smidt, Steen B Pedersen, Birgitte Brock, et al.
Frontiers in Pharmacology|December 6, 2016
Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis RatsBrian DellaValle, Gitte S Brix, Birgitte Brock, et al.
World Journal of Diabetes|February 22, 2019
Quantities of comorbidities affects physical, but not mental health related quality of life in type 1 diabetes with confirmed polyneuropathyAnne-Marie L Wegeberg, Theresa Meldgaard, Sofie Hyldahl, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysisMikkel Tøttrup, Tore Forsingdal Hardlei, Michael Bendtsen, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2015
Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumoniaKristina Öbrink-Hansen, Tore Forsingdal Hardlei, Birgitte Brock, et al.
Expert Opinion on Therapeutic Targets|July 14, 2011
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetesAnn Mosegaard Bak, Lærke Egefjord, Michael Gejl, et al.
Basic & Clinical Pharmacology & Toxicology|August 25, 2015
Detection of Patients at High Risk of Medication Errors: Development and Validation of an AlgorithmEva Aggerholm Saedder, Marianne Lisby, Lars Peter Nielsen, et al.
Basic & Clinical Pharmacology & Toxicology|February 24, 2021
Subcutaneous adipose tissue composition and function are unaffected by liraglutide-induced weight loss in adults with type 1 diabetesAnne-Marie Wegeberg, Theresa Meldgaard, Amanda Baek, et al.
Scientific Reports|July 13, 2023
Adynamic response to cold pain reflects dysautonomia in type 1 diabetes and polyneuropathyThomas Arendt Nielsen, Søren Lundbye-Christensen, Yoanna Krasimirova Dimitrova, et al.
Pageof 10